Search results for CD123

Anti-CD123/IL3RA Antibody (R3H19), AntibodySystem, RHD72502

Anti-CD123/IL3RA Antibody (R3H20), AntibodySystem, RHD72503

Spark Red™ 718 anti-human CD123 (Flexi-Fluor™) Antibody, CD123, 6H6, BioLegend, 285054

Clone 6H6 does not inhibit IL-3 binding to low- or high-affinity IL-3Rs. Additional reported applications (for the relevant formats) include: Western blotting1, immunoprecipitation1, and immunohistochemical staining of acetone-fixed frozen sections2and also paraformaldehyde fixed paraffin embedded tissue7.

Spark YG™ 581 anti-human CD123 (Flexi-Fluor™) Antibody, CD123, 6H6, BioLegend, 285381

Clone 6H6 does not inhibit IL-3 binding to low- or high-affinity IL-3Rs. Additional reported applications (for the relevant formats) include: Western blotting1, immunoprecipitation1, and immunohistochemical staining of acetone-fixed frozen sections2and also paraformaldehyde fixed paraffin embedded tissue7.

Spark YG™ 593 anti-human CD123 (Flexi-Fluor™) Antibody, CD123, 6H6, BioLegend, 285426

Clone 6H6 does not inhibit IL-3 binding to low- or high-affinity IL-3Rs. Additional reported applications (for the relevant formats) include: Western blotting1, immunoprecipitation1, and immunohistochemical staining of acetone-fixed frozen sections2and also paraformaldehyde fixed paraffin embedded tissue7.

PE Anti-IL3RA/CD123 antibody [6H6], Abcam, AB93523

APC Rabbit anti-Human CD123 mAb, ABclonal, A28487

PE Rabbit anti-Human CD123 mAb, ABclonal, A28488

Anti-IL3RA/CD123 antibody [EPR23188-72], Abcam, AB222103

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-IL3RA/CD123 antibody [EPR24481-20], Abcam, AB280355

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .